<DOC>
	<DOCNO>NCT01068093</DOCNO>
	<brief_summary>The purpose study assess effect Ezetimibe coronary plaque volume patient acute coronary syndrome .</brief_summary>
	<brief_title>The Effects Ezetimibe Coronary Plaque Volume Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description>Previous study report administration statins patient coronary artery disease result significant reduction low-density lipoprotein cholesterol ( LDL-C ) regression coronary plaque volume , decrease level LDL-C statin treatment positively correlate reduction volume plaque . Administration Ezetimibe addition statin show effective reduce LDL-C level compare statin monotherapy . However , effect Ezetimib coronary plaque volume remain unclear . In study , investigator assess effect Ezetimibe coronary plaque volume tissue composition patient acute coronary syndrome .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>1 . Patients diagnose acute coronary syndrome , successful percutaneous coronary intervention ( PCI ) perform intravascular ultrasound ( IVUS ) guidance . 2 . Patients coronary plaque ( ≧ 500 µm thickness % plaque 20 % ≧ 5 mm distal proximal previously treat area branch coronary artery . 1 . Patients bypass graft instent restenosis site PCI . 2 . Patients receive PCI past lesion evaluation coronary plaque volume plan . 3 . Patients plaques nonculprit site might receive PCI treatment period . 4 . Patients receive lipidlowering drug ( statin , fibrates , probucol , nicotinic acid cholesterol absorption inhibitor ) . 5 . Patients familial hypercholesterolemia . 6 . Patients cardiogenic shock . 7 . Patients receive cyclosporine . 8 . Patients allergy Ezetimibe . 9 . Patients hepatobiliary disorder . 10 . Pregnant woman , woman suspect pregnant , lactating woman . 11 . Patients renal disorder undergoing dialysis . 12 . Patients ineligible opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>